The awards recognise and celebrate the outstanding contribution our local businesses make to the social, environmental, and economic wellbeing of our community. Avance Clinical has won the category for International Health that recognises the company’s outstanding international success in biotechnology and healthcare industry.

For the fourth consecutive year, Avance Clinical has been awarded Best Practices Customer Value Leadership awarded, by Frost & Sullivan, for its exceptional performance.

Read the full press release HERE

Chief Executive Officer Yvonne Lungershausen has been nominated for Executive of the Year in the 2023 Citeline Pharma Intelligence Awards in Japan. This Award acknowledges excellence in leadership and recognises the executive who has exhibited exemplary leadership. It highlights the executive’s career achievements, influence within the industry and characteristics that make a good leader, such as decisive and clear strategy, team building and employee welfare.

The Awards for the Best Contract Research Organization acknowledge the critical role that CROs play in drug development. As a specialist early stage CRO, Avance has been delivering clinical drug development services for international biotechs for over two decades. The team at Avance are passionate about bringing tailored, innovative solutions geared to suit the needs of biotechnology companies.

Winners will be announced on November 16, 2023, in London.

Scrip’s Business Development Team of the Year Award honours the achievements of business development teams whether they are from a pharma or biotech company or a cross-company team responsible for a specific deal or collaborative project.

The Avance Clinical business development team is much more than the sum of its parts, playing a pivotal role in expediting the clinical development journey for biotech companies across the globe.

Frost & Sullivan has recognized Avance Clinical, the leading Australian-based biotech CRO with US operations, with the Frost & Sullivan’s 2022 Asia-Pacific Customer Value Leadership Award. Avance Clinical’s approach goes beyond its extensive expertise and best-in-class capabilities, with customer value as a strategic imperative. Through the years, the company has earned an outstanding reputation supporting clients’ path toward seamless clinical trial execution.

Read the full press release HERE

Avance Clinical won the 2022 South Australian Premier’s Export Awards – International Health category. The award recognises excellence in clinical services exports.

This Award recognizes CROs that provide full or specialist services to their clients and which have an office in either in Japan or the Asia region including Australia. Avance Clinical has been selected as a finalist for this prestigious award, having shown high growth and industry-leading repeat business rates that focus on gold standard technology paired with solution-orientated clinical experts.

Read the full press release HERE

Avance Clinical has won the Fast Movers SA Excellence in Business Award 2021 sponsored by international accounting and business advisory firm BDO. This award recognises a company that has achieved exceptional and sustained growth year on year, and demonstrates innovative strategies and market leadership, as shown by leading CRO Avance Clinical.

Read the full press release HERE

Avance Clinical is recognised as winner for Frost & Sullivan 2020 Asia-Pacific Market Leadership Award that aims at motivating firms to continue pushing the boundaries of excellence year after year.

Read the full press release HERE